Outcomes Leader Dr. Ware Elected Charter Fellow of Prestigious
National Academy of Inventors

January 15, 2013 03:21 PM Eastern Standard Time

WORCESTER, Mass.--(BUSINESS WIRE)--Dr.
John E. Ware, Jr., Chief Science Officer and Founder of John
Ware Research Group, Inc. (JWRG), a leading health outcomes company,
is elected a Charter Fellow of the National
Academy of Inventors (NAI). The NAI recognizes inventors who hold
U.S. patents. Nominated by the University of Massachusetts Medical
School where Dr. Ware is also Professor and Chief of the Outcomes
Measurement Sciences Division, Dr. Ware said, "it is an honor to be an
NAI Charter Fellow and to be in the company of such distinguished
innovators." Dr. Ware, holder of numerous awards, is a globally
recognized inventor of the patient reported outcomes (PRO) field. PROs
are used in clinical trials and healthcare, including medical practice
and electronic health records. PROs measure treatment outcomes, now at
the forefront of healthcare reform.

The newly elected NAI class of Fellows is comprised of inventors and
innovators from 56 global research universities and non-profit research
institutes who, collectively, hold over 3,200 U.S. patents. Included
among the Fellows are eight Nobel Laureates, 14 presidents of research
universities and non-profit research institutes. Dr. Ware is one of 53
members from the National Academies (National Academy of Sciences,
National Academy of Engineering, Institute of Medicine), 11 inductees of
the National Inventors Hall of Fame, two Fellows of the Royal Society,
five recipients of the National Medal of Technology and Innovation, four
recipients of the National Medal of Science, and 31 AAAS Fellows.

Dr. Ware's first patent brought computer adaptive testing (CAT) to the
PRO field for which he is a global thought leader. CAT made it practical
to quantify the voice of the patient in clinical trials and in
healthcare before and after treatments. This advance has been adopted by
the National Institutes of Health (NIH) as the standard for more
practical health measurement in the Patient Reported Outcomes Management
Information System (PROMIS®) for which Dr. Ware is a
collaborator.

Dr. Ware's second patent (pending) is for inventing a more comprehensive Quality
of Life Information System (QOLIX®) which integrates
disease-specific and generic PROs using an adaptive
survey logic (ASLX®), a breakthrough in administering
briefer surveys which produce more useful and interpretable data in
real-time to clinicians, study sponsors, and patients.